During the past few years, interest in the development of novel drug delivery systems for existing drug molecules has been renewed. The development of a novel delivery system for existing drug molecules not only improves the drug's performance in terms of efficacy and safety but also improves patient compliance and overall therapeutic benefit to a significant extent. Transdermally delivered drugs avoid the risk and inconvenience of intravenous therapy, usually provide less chance of an overdose or underdose, allow easy termination, and permit both local and systemic treatment effects. Transdermal drug delivery offers controlled release of the drug into the patient, it enables a steady blood level profile, resulting in reduced systemic side effects and, sometimes, improved efficacy over other dosage forms. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intra patient variation. The growth rate for transdermal drug delivery systems is expected to increase 12% annually by 2007.
"Sinopsis" puede pertenecer a otra edición de este libro.
During the past few years, interest in the development of novel drug delivery systems for existing drug molecules has been renewed. The development of a novel delivery system for existing drug molecules not only improves the drug's performance in terms of efficacy and safety but also improves patient compliance and overall therapeutic benefit to a significant extent. Transdermally delivered drugs avoid the risk and inconvenience of intravenous therapy, usually provide less chance of an overdose or underdose, allow easy termination, and permit both local and systemic treatment effects. Transdermal drug delivery offers controlled release of the drug into the patient, it enables a steady blood level profile, resulting in reduced systemic side effects and, sometimes, improved efficacy over other dosage forms. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intra patient variation. The growth rate for transdermal drug delivery systems is expected to increase 12% annually by 2007.
Sudip Debnath is currently pursuing MSc in Medical Cell Biology at University of Bergen, Norway. Prior to that he did his BSc and MS from Biochemistry and Molecular Biology, University of Dhaka. He had more than three years of professional experience in Eskayef Bangladesh Limited. Besides academic activities, Debnath is closely involved to research
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - During the past few years, interest in the development of novel drug delivery systems for existing drug molecules has been renewed. The development of a novel delivery system for existing drug molecules not only improves the drug's performance in terms of efficacy and safety but also improves patient compliance and overall therapeutic benefit to a significant extent. Transdermally delivered drugs avoid the risk and inconvenience of intravenous therapy, usually provide less chance of an overdose or underdose, allow easy termination, and permit both local and systemic treatment effects. Transdermal drug delivery offers controlled release of the drug into the patient, it enables a steady blood level profile, resulting in reduced systemic side effects and, sometimes, improved efficacy over other dosage forms. The main objective of transdermal drug delivery system is to deliver drugs into systemic circulation through skin at predetermined rate with minimal inter and intra patient variation. The growth rate for transdermal drug delivery systems is expected to increase 12% annually by 2007. Nº de ref. del artículo: 9783659163821
Cantidad disponible: 2 disponibles
Librería: moluna, Greven, Alemania
Kartoniert / Broschiert. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Debnath SudipSudip Debnath is currently pursuing MSc in Medical Cell Biology at University of Bergen, Norway. Prior to that he did his BSc and MS from Biochemistry and Molecular Biology, University of Dhaka. He had more than three ye. Nº de ref. del artículo: 5136192
Cantidad disponible: Más de 20 disponibles
Librería: Revaluation Books, Exeter, Reino Unido
Paperback. Condición: Brand New. 56 pages. 8.66x5.91x0.13 inches. In Stock. Nº de ref. del artículo: zk3659163821
Cantidad disponible: 1 disponibles
Librería: preigu, Osnabrück, Alemania
Taschenbuch. Condición: Neu. Transdermal Drug Delivery System | To deliver drugs into systemic circulation through skin | Sudip Debnath (u. a.) | Taschenbuch | Englisch | LAP Lambert Academic Publishing | EAN 9783659163821 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Nº de ref. del artículo: 106380697
Cantidad disponible: 5 disponibles
Librería: Mispah books, Redhill, SURRE, Reino Unido
Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Nº de ref. del artículo: ERICA79636591638216
Cantidad disponible: 1 disponibles